Bioage Labs (FRA:Y7G) ROCE %: -27.53% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:Y7G Bioage Labs Inc FRA:Y7G
12 GF Score
Price €9.06
! 3 Warning Signs
View Full Analysis

What is Bioage Labs ROCE %?

Bioage Labs FRA:Y7G -7.17% 12 ROCE % is -27.53% as of Jun. 2026. GuruFocus rates FRA:Y7G with a GF Score™ of 12/100. The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bioage Labs's annualized ROCE % for the quarter that ended in Jun. 2026 was -27.53%.

Bioage Labs  (FRA:Y7G) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bioage Labs ROCE % Related Terms

Bioage Labs ROCE % Historical Data

* Premium members only.

The historical data trend for Bioage Labs's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioage Labs ROCE % Chart

Bioage Labs Annual Data
Trend Dec22 Dec23 Dec24 Dec25
ROCE %
-174.94 0.00 -45.91 -24.80

Bioage Labs Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -26.67 -27.37 -37.28 -27.21 -27.53
FRA:Y7G
12GF Score
Bioage Labs Inc FRA:Y7G
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bioage Labs ROCE % Calculation

Bioage Labs's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-68.241/( ( (342.113 - 26.525) + (251.835 - 17.198) )/ 2 )
=-68.241/( (315.588+234.637)/ 2 )
=-68.241/275.1125
=-24.80 %

Bioage Labs's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=-90.604/( ( (343.971 - 13.69) + (344.534 - 16.68) )/ 2 )
=-90.604/( ( 330.281 + 327.854 )/ 2 )
=-90.604/329.0675
=-27.53 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -27.53% mean?
Bioage Labs (FRA:Y7G) has a ROCE % of -27.53% as of Jun. 2026.
Is Bioage Labs' ROCE % too high?
Bioage Labs' current ROCE % is -27.53%. Overall, Bioage Labs has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Bioage Labs' ROCE % compare to PCRX and ALVO?
Bioage Labs' ROCE % of -27.53% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 6.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 6.91, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 6.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioage Labs's current ROCE % is -27.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioage Labs stock overvalued right now?
Bioage Labs (FRA:Y7G) has a current ROCE % of -27.53%. The current ROCE % is -27.53%. Bioage Labs' overall GF Score™ is 12/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Bioage Labs (FRA:Y7G), the current ROCE % is -27.53% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bioage Labs Business Description

Other Exchanges BIOA:USA
Address 1445A South 50th Street, Richmond, CA, USA, 94804
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
12GF Score

Get the complete analysis for FRA:Y7G

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.06
Price